RT Journal Article
SR Electronic
T1 Social Network Analysis of COVID-19 Transmission in Karnataka, India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.11.20172734
DO 10.1101/2020.08.11.20172734
A1 Saraswathi, S.
A1 Mukhopadhyay, A.
A1 Shah, H.
A1 Ranganath, T.S.
YR 2020
UL http://medrxiv.org/content/early/2020/09/01/2020.08.11.20172734.abstract
AB We used social network analysis (SNA) to study the novel coronavirus (COVID-19) outbreak in Karnataka, India, and assess the potential of SNA as a tool for outbreak monitoring and control. We analyzed contact tracing data of 1147 Covid-19 positive cases (mean age 34.91 years, 61.99% aged 11–40, 742 males), anonymized and made public by the government. We used software tools Cytoscape and Gephi to create SNA graphics and determine network attributes of nodes (cases) and edges (directed links, determined by contact tracing, from source to target patients). Outdegree was 1–47 for 199 (17.35%) nodes, and betweenness 0.5–87 for 89 (7.76%) nodes. Men had higher mean outdegree and women, higher betweenness. Delhi was the exogenous source of 17.44% cases. Bangalore city had the highest caseload in the state (229, 20%), but comparatively low cluster formation. Thirty-four (2.96%) “super-spreaders” (outdegree≥5) caused 60% of the transmissions. Real-time social network visualization can allow healthcare administrators to flag evolving hotspots and pinpoint key actors in transmission. Prioritizing these areas and individuals for rigorous containment could help minimize resource outlay and potentially achieve a significant reduction in COVID-19 transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We used anonymized secondary data available in the public domain, from a government website, the copyright policy of which indicates that the data may be used for publication subject to proper acknowledgment.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used anonymized secondary data available in the public domain, from a government website, the copyright policy of which indicates that the data may be used for publication subject to proper acknowledgment. Archived bulletins will be made available on reasonable request from the principal author. https://covid19.karnataka.gov.in/govt_bulletin/en#